Scott Centea's most recent trade in Angiodynamic Inc was a trade of 333 Common Stock done at an average price of $8.7 . Disclosure was reported to the exchange on July 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.74 per share. | 20 Jul 2023 | 333 | 58,383 (0%) | 0% | 8.7 | 2,910 | Common Stock |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.65 per share. | 20 Jul 2023 | 255 | 58,128 (0%) | 0% | 8.7 | 2,206 | Common Stock |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 11,782 | 0 | - | - | Performance Right | |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 3,415 | 61,543 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.92 per share. | 19 Jul 2023 | 1,230 | 60,313 (0%) | 0% | 8.9 | 10,972 | Common Stock |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.63 per share. | 14 Jul 2023 | 517 | 48,479 (0%) | 0% | 9.6 | 4,979 | Common Stock |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.56 per share. | 14 Jul 2023 | 351 | 48,128 (0%) | 0% | 9.6 | 3,356 | Common Stock |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 8,680 | 8,680 | - | - | Non- Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 7,410 | 7,410 | - | - | Performance Right | |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 3,705 | 48,996 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Scott Centea | Sr. VP/GM, Global VIT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.37 per share. | 31 Oct 2021 | 953 | 45,291 (0%) | 0% | 29.4 | 27,990 | Common Stock |
| Angiodynamic Inc | Scott Centea | Sr. VP/GM, Global VIT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.77 per share. | 15 Oct 2021 | 12,000 | 58,244 (0%) | 0% | 16.8 | 201,240 | Common Stock |
| Angiodynamic Inc | Scott Centea | Sr. VP/GM, Global VIT | Sale of securities on an exchange or to another person at price $ 27.92 per share. | 15 Oct 2021 | 12,000 | 46,244 (0%) | 0% | 27.9 | 335,040 | Common Stock |
| Angiodynamic Inc | Scott Centea | Sr. VP/GM, Global VIT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2021 | 12,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Scott Centea | Sr. VP/GM, Global VIT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.10 per share. | 26 Jul 2021 | 419 | 46,244 (0%) | 0% | 26.1 | 10,936 | Common Stock |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 7,721 | 7,721 | - | - | Non-Qualified Stock Option (right to buy) | |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 5,684 | 5,684 | - | - | Performance Right | |
| Angiodynamic Inc | Scott Centea | SVP/GM, VIT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.62 per share. | 31 Oct 2020 | 849 | 45,004 (0%) | 0% | 10.6 | 9,016 | Common Stock |